Company profile ARTL
After 34 days of this quarter the interest is at 62.0. Based on that we can calculate that during remaining 58 days it will total up to 168.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 23 |
| 2019 | 34 47.8% QoQ | 75 120.6% QoQ | 165 120.0% QoQ | 133 478.3% YoY -19.4% QoQ |
| 2020 | 135 297.1% YoY 1.5% QoQ | 59 -21.3% YoY -56.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 134 inf% YoY inf% QoQ | 175 inf% YoY 30.6% QoQ | 130 inf% YoY -25.7% QoQ |
| 2023 | 166 inf% YoY 27.7% QoQ | 80 -40.3% YoY -51.8% QoQ | 155 -11.4% YoY 93.8% QoQ | 62 -52.3% YoY -60.0% QoQ |
The average 5 years interest of Artelo Biosciences was 5.85 per week. The last year interest of Artelo Biosciences compared to the last 5 years has changed by 89.06%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 74.17%.
There is not enough data for Endocannabinoid system treatments to provide analysis
There is not enough data for Endocannabinoid system treatments to provide correlation calculation
There is not enough data for Endocannabinoid system treatments to provide analysis
There is not enough data for ART27.13 clinical trial to provide analysis
There is not enough data for ART27.13 clinical trial to provide correlation calculation
There is not enough data for ART27.13 clinical trial to provide analysis
There is not enough data for ART12.11 inflammatory bowel disease to provide analysis
There is not enough data for ART12.11 inflammatory bowel disease to provide correlation calculation
There is not enough data for ART12.11 inflammatory bowel disease to provide analysis
There is not enough data for ART12.11 PTSD to provide analysis
There is not enough data for ART12.11 PTSD to provide correlation calculation
There is not enough data for ART12.11 PTSD to provide analysis
There is not enough data for ART26.12 FABP5 inhibitor to provide analysis
There is not enough data for ART26.12 FABP5 inhibitor to provide correlation calculation
There is not enough data for ART26.12 FABP5 inhibitor to provide analysis
After 39 days of this quarter the interest is at 395.0. Based on that we can calculate that during remaining 52 days it will total up to 922.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 604 | 852 41.1% QoQ | 763 -10.4% QoQ | 894 17.2% QoQ |
| 2020 | 922 52.6% YoY 3.1% QoQ | 725 -14.9% YoY -21.4% QoQ | 840 10.1% YoY 15.9% QoQ | 848 -5.1% YoY 1.0% QoQ |
| 2021 | 750 -18.7% YoY -11.6% QoQ | 778 7.3% YoY 3.7% QoQ | 788 -6.2% YoY 1.3% QoQ | 824 -2.8% YoY 4.6% QoQ |
| 2022 | 864 15.2% YoY 4.9% QoQ | 850 9.3% YoY -1.6% QoQ | 786 -0.3% YoY -7.5% QoQ | 850 3.2% YoY 8.1% QoQ |
| 2023 | 1033 19.6% YoY 21.5% QoQ | 918 8.0% YoY -11.1% QoQ | 808 2.8% YoY -12.0% QoQ | 1045 22.9% YoY 29.3% QoQ |
| 2024 | 395 -61.8% YoY -62.2% QoQ | - | - | - |
The average 5 years interest of Cancer treatments was 65.66 per week. The last year interest of Cancer treatments compared to the last 5 years has changed by 8.6%. The interest for Cancer treatments is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by 5.94%.
After 39 days of this quarter the interest is at 342.0. Based on that we can calculate that during remaining 52 days it will total up to 798.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 680 | 1077 58.4% QoQ | 1105 2.6% QoQ | 1010 -8.6% QoQ |
| 2020 | 1048 54.1% YoY 3.8% QoQ | 849 -21.2% YoY -19.0% QoQ | 987 -10.7% YoY 16.3% QoQ | 956 -5.3% YoY -3.1% QoQ |
| 2021 | 1027 -2.0% YoY 7.4% QoQ | 1097 29.2% YoY 6.8% QoQ | 1092 10.6% YoY -0.5% QoQ | 1057 10.6% YoY -3.2% QoQ |
| 2022 | 1067 3.9% YoY 0.9% QoQ | 1028 -6.3% YoY -3.7% QoQ | 1075 -1.6% YoY 4.6% QoQ | 964 -8.8% YoY -10.3% QoQ |
| 2023 | 1017 -4.7% YoY 5.5% QoQ | 1032 0.4% YoY 1.5% QoQ | 1017 -5.4% YoY -1.5% QoQ | 1024 6.2% YoY 0.7% QoQ |
| 2024 | 342 -66.4% YoY -66.6% QoQ | - | - | - |
The average 5 years interest of Pain management was 78.74 per week. The last year interest of Pain management compared to the last 5 years has changed by -3.43%. The interest for Pain management is stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -8.39%.
After 39 days of this quarter the interest is at 215.0. Based on that we can calculate that during remaining 52 days it will total up to 502.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 473 | 594 25.6% QoQ | 451 -24.1% QoQ | 588 30.4% QoQ |
| 2020 | 565 19.5% YoY -3.9% QoQ | 563 -5.2% YoY -0.4% QoQ | 476 5.5% YoY -15.5% QoQ | 618 5.1% YoY 29.8% QoQ |
| 2021 | 500 -11.5% YoY -19.1% QoQ | 543 -3.6% YoY 8.6% QoQ | 413 -13.2% YoY -23.9% QoQ | 557 -9.9% YoY 34.9% QoQ |
| 2022 | 625 25.0% YoY 12.2% QoQ | 760 40.0% YoY 21.6% QoQ | 505 22.3% YoY -33.6% QoQ | 756 35.7% YoY 49.7% QoQ |
| 2023 | 690 10.4% YoY -8.7% QoQ | 720 -5.3% YoY 4.3% QoQ | 499 -1.2% YoY -30.7% QoQ | 803 6.2% YoY 60.9% QoQ |
| 2024 | 215 -68.8% YoY -73.2% QoQ | - | - | - |
The average 5 years interest of Anxiety disorders was 45.65 per week. The last year interest of Anxiety disorders compared to the last 5 years has changed by 12.18%. The interest for Anxiety disorders is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 16.04%.
After 39 days of this quarter the interest is at 81.0. Based on that we can calculate that during remaining 52 days it will total up to 189.0. Artelo Biosciences stock expected interest is significantly higher compared to previous quarter (+136.2%) and same quarter last year (+96.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 25 | 105 320.0% QoQ | 164 56.2% QoQ | 210 28.0% QoQ |
| 2020 | 105 320.0% YoY -50.0% QoQ | 167 59.0% YoY 59.0% QoQ | 104 -36.6% YoY -37.7% QoQ | 80 -61.9% YoY -23.1% QoQ |
| 2021 | 344 227.6% YoY 330.0% QoQ | 85 -49.1% YoY -75.3% QoQ | 58 -44.2% YoY -31.8% QoQ | 90 12.5% YoY 55.2% QoQ |
| 2022 | 84 -75.6% YoY -6.7% QoQ | 25 -70.6% YoY -70.2% QoQ | 111 91.4% YoY 344.0% QoQ | 55 -38.9% YoY -50.5% QoQ |
| 2023 | 96 14.3% YoY 74.5% QoQ | 112 348.0% YoY 16.7% QoQ | 165 48.6% YoY 47.3% QoQ | 80 45.5% YoY -51.5% QoQ |
| 2024 | 81 -15.6% YoY 1.2% QoQ | - | - | - |
The average 5 years interest of Artelo Biosciences stock was 8.99 per week. The last year interest of Artelo Biosciences stock compared to the last 5 years has changed by 0.78%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -12.29%.